Birt–Hogg–Dubé syndrome
Jump to navigation
Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Birt–Hogg–Dubé syndrome, also Hornstein-Birt-Hogg-Dubé syndrome,[1] is constellation of findings due to a FLCN (folliculin) gene mutation.[2] It is abbreviated BHD syndrome.
Features
BHD syndrome is characterized by:[3][4]
- Skin lesions of face, neck and anterior trunk (~80% of individuals with syndrome):
- Fibrofolliculoma.
- Trichodiscoma.
- Acrochordon.
- Renal tumours (~25-35% of individuals):
- Variable penetrance (autosomal dominant).
- Lung cysts - inferior to carina (~80% of individuals with syndrome).
- Multiple basal lung cysts - may be significant.[6]
- Spontaneous pneumothorax (~25% of individuals with syndrome).[4]
Note:
- May be seen with a mix of oncocytic renal tumours - known as renal oncocytosis.
See also
References
- ↑ Happle, R. (Jun 2012). "Hornstein-Birt-Hogg-Dubé syndrome: a renaming and reconsideration.". Am J Med Genet A 158A (6): 1247-51. doi:10.1002/ajmg.a.35330. PMID 22581760.
- ↑ Online 'Mendelian Inheritance in Man' (OMIM) 135150
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 290. ISBN 978-0781765275.
- ↑ 4.0 4.1 Furuya, M.; Yao, M.; Tanaka, R.; Nagashima, Y.; Kuroda, N.; Hasumi, H.; Baba, M.; Matsushima, J. et al. (Nov 2016). "Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dubé syndrome.". Clin Genet 90 (5): 403-412. doi:10.1111/cge.12807. PMID 27220747.
- ↑ Hes, O.; Petersson, F.; Kuroda, N.; Hora, M.; Michal, M. (Oct 2013). "Renal hybrid oncocytic/chromophobe tumors - a review.". Histol Histopathol 28 (10): 1257-64. PMID 23740406.
- ↑ Johannesma, PC.; Houweling, AC.; Menko, FH.; van de Beek, I.; Reinhard, R.; Gille, JJ.; van Waesberghe, JT.; Thunnissen, E. et al. (Apr 2016). "Are lung cysts in renal cell cancer (RCC) patients an indication for FLCN mutation analysis?". Fam Cancer 15 (2): 297-300. doi:10.1007/s10689-015-9853-5. PMID 26603437.